K Number
K073709
Manufacturer
Date Cleared
2008-03-11

(71 days)

Product Code
Regulation Number
892.1550
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The ViewMate® System is intended to be used to visualize cardiac structures and blood flow within the heart.

The ViewMate® System is indicated for use in adult and adolescent pediatric patients to visualize cardiac structures and blood flow within the heart.

Device Description

The ViewMate® System is a portable, computerized, ultrasound imaging system used to display and capture intracardiac ultrasound images. The ViewMate® System is comprised of three components: ViewMate® console, patient isolation module and the ViewFlex® PLUS ultrasound catheter. The ViewMate® ultrasound console comprises a personal computer (PC), ultrasound imaging beam former and a digital frame grabber with storage. The system software is used to control imaging modes, image quality, image acquisition, storage, and retrieval of patient records (i.e., images, ECG, and notes). The system software enables multiple imaging modes: two dimensional (B mode and color Doppler) and time-motion mode (spectral Doppler/puise wave Doppler and M Mode) Additional software functionality includes zoom, labeling, image storage, retrieval and review. ViewMate® may be used in interventional cardiology, specifically in the interventional EP laboratory. The ViewMate® connects with an ultrasound catheter called ViewFlex® PLUS that is inserted into the heart via intravascular access. The ViewFlex® PLUS catheter is a single use, temporary, intracardiac ultrasound catheter indicated for use in adult and adolescent pediatric patients. The catheter shaft is 9 French, approximately 90 cm long, constructed of radio-opaque tubing. The catheter offers bi-directional steerability that can be manipulated with one hand. The catheter consists of a 64-element linear phased array, wideband transducer with an imaging frequency range of 4.5 MHz to 8.5 MHz, user-selectable magnification, 86° viewing angle on the ViewMate® I system and a viewing angle of 90° on the ViewMate® II system.

AI/ML Overview

This document does not contain information about studies conducted to prove the device meets acceptance criteria. The document describes a 510(k) submission for a modification to an existing medical device, the ViewFlex® catheter, now branded as ViewFlex® PLUS. It focuses on the mechanical design changes, their reasons, and the fact that the ultrasound transducer, its performance, and the intended use/indications for use are not affected by these proposed changes.

Therefore, the requested information regarding acceptance criteria, study details, sample sizes, expert qualifications, adjudication methods, MRMC studies, standalone performance, and ground truth establishment cannot be extracted from the provided text because no such studies are described for this modification.

The document primarily serves as a notification for modifications to a previously cleared device, asserting that the core functionality related to ultrasound imaging remains unchanged from the predicate device.

Key takeaway from the document: The submission explicitly states "No changes have been made to the ultrasound or electronics design of the catheter; the ultrasound transducer and its performance is not affected by the proposed changes." This implies that the performance characteristics relating to imaging (which would typically be evaluated against acceptance criteria) are assumed to be equivalent to the predicate device and no new studies are presented to re-evaluate them.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo for EPMedSystems. The logo consists of a stylized, abstract symbol to the left of the text "EPMedSystems". The symbol appears to be a series of curved lines or strokes, possibly representing a heart or other medical-related imagery. The text is in a bold, sans-serif font, with "EPMedSystems" written in a single line.

510(k) Summary

Summary preparation date: 12/28/07

1. Device Trade Name

Device Trade NameDevice Classification
ViewMate® System
This application describes a modification to theViewMate® System's catheter called ViewFlex® PLUS.

MAR 1 1 2008

2. Establishment Address and Registration

EP MedSystems Inc. Cooper Run Executive Park 575 Route 73 North, Building D West Berlin, NJ 08091-9293 USA

Larry Picciano Telephone: 856-753-8533, x221 Fax: 856-753-8544 E-mail: Ipicciano@epmedsystems.com

US Food and Drug Administration Establishment Registration No.: 2248049

ClassificationProductCodeDeviceClassificationNameRegulationNumberClassificationNumberPerformanceStandard(s)
PrimaryIYNSystem,Imaging, PulsedDoppler,Ultrasonic892.1550IINone
SubsequentITXTransducer,Ultrasonic892.1570IINone
SubsequentIYOSystem,Imaging, PulsedEcho, Ultrasonic892.1560IINone

3. Device Classification

4. Predicate Devices / Technology

Product Description510 (k) No.Date
ViewMate® System03106610/17/03
ViewMate® System07102805/01/07

This document is the property of EPMedSystems. Its' entire content is considered proprietary and confidential by EP MedSystems. This document may not be copied, reproduced, published or disclosed to others, in whole or in part, without express written consent of EPMedSystems' executive management.

{1}------------------------------------------------

Image /page/1/Picture/0 description: The image shows the logo for EPMedSystems. The logo consists of a stylized graphic to the left of the company name. The graphic is a black, abstract shape, and the company name is written in a bold, serif font.

5. Labeling and Intended Use

The following draft labeling is contained within Appendix 4.

  • 5.1. Product Labeling
  • 5.2. Marketing Literature
  • 5.3. Instructions for Use

6. Intended Use

The ViewMate® System is intended to be used to visualize cardiac structures and blood flow within the heart.

7. Indications for Use

The ViewMate® System is indicated for use in adult and adolescent pediatric patients to visualize cardiac structures and blood flow within the heart

Note: A copy of the original Diagnostic Ultrasound Indications for Use Form (K031066), which is not affected by this notification, is provided in Appendix 5.

8. Device Description

  • 8.1. The purpose of this submission is to provide premarket notifications to the mechanical design of the ViewFlex® catheter; the modified device will be marketed as ViewFlex® PLUS catheter (model VF-PM). The intended use and indications for use of the ViewFiex® catheter are not affected. No changes have been made to the ultrasound or electronics design of the catheter; the ultrasound transducer and its performance is not affected by the proposed changes. Similarly, no changes have been made to the ViewMate® or the ViewMate® II (PMS HD11 XE) console.
  • 8.2. Background of the ViewMate® System with the ViewFlex® Catheter: The ViewFlex® ultrasound catheter in combination with the ViewMate® cardiac ultrasound imaging console was first cleared for US marketing on October 17, 2003 (K031066). Clearance to market a modification to the ViewFlex® catheter was received on May 1, 2007 (K071028). On August 18, 2006 EPMedSystems' ViewFlex® catheter was cleared for US marketing with Philips Medical Systems' (PMS) HD11 XE Ultrasound System (K062247). On January 9, 2007 EPMedSystems (the company) entered into a contractual agreement with PMS to market the HD11 XE under the EPMedSystems trade name ViewMate® II. As a US registered medical device distributor, re-packager and re-labeler, EPMedSystems has been distributing the ViewMate® II console. The company plans to continue distributing the ViewMate® II console for use with ViewFlex® catheters.
  • 8.3. General Description of the ViewMate® System with the ViewFlex® PLUS Catheter: The ViewMate® cardiac ultrasound imaging system (K031066 and K071028) is intended to be used to visualize cardiac structures and blood flow within the heart; it is indicated for use in adult and adolescent pediatric patients. The ViewMate® system's intracardiac imaging capability is used by Electrophysiologists and Interventional Cardiologists in a number of ways, including

but not limited to, assessing cardiac output, determining the size of the heart and This document is the property of EPMedSystems. Its' entire considered proprietary and confidential by EP MedSystems. This document may not be copied, reproduced, published to others, in whole or in part, without express written consent of EPMedSystems' executive management.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the logo for EPMedSystems. The logo consists of a stylized graphic to the left of the text "EPMedSystems". The graphic is a black, abstract shape. The text is in a bold, sans-serif font.

ViewFlex TMCatheter Modification VF-PM :510k Summary

locating its structures, determining device location (e.g., electrophysiology catheters, pacing leads, PFO closure devices), positioning of devices, and visualizing blood flow through cardiac arteries. Cardiac electrophysiology (EP) procedures are complex diagnostic tests during which physicians look at electrical signals from the heart to determine if an abnormality (arrhythmia) exists. Use of the ViewMate® system in EP studies offers significant advantages in that it enables physicians to accurately place EP catheters and to identify physiologic and blood flow anomalies. Interventional Cardiologists have recently begun using ViewMate® to view structures and devices during interventional cardiac procedures as well.

  • 8.4. The ViewMate® System is a portable, computerized, ultrasound imaging system used to display and capture intracardiac ultrasound images. The ViewMate® System illustrated in Figure 1 is comprised of three components. ViewMate® console, patient isolation module and the ViewFlex® PLUS ultrasound catheter.
    Image /page/2/Figure/5 description: The image shows a diagram of a medical system. The system includes a monitor, a ViewMate console, an isolation module, a 12-lead ECG cable, and a ViewFlex catheter. The system is used by a physician to monitor and treat a patient.

Figure 1: ViewMate® System

*Note: ViewMate II ECG connects directly to console with internal isolation.

  • 8.5. The ViewMate® ultrasound console comprises a personal computer (PC), ultrasound imaging beam former and a digital frame grabber with storage. The system software is used to control imaging modes, image quality, image acquisition, storage, and retrieval of patient records (i.e., images, ECG, and notes). The system software enables multiple imaging modes: two dimensional (B mode and color Doppler) and time-motion mode (spectral Doppler/puise wave Doppler and M Mode) Additional software functionality includes zoom, labeling, image storage, retrieval and review. ViewMate® may be used in interventional cardiology, specifically in the interventional EP laboratory.
  • 8.6. Description of ViewFlex® PLUS Catheter: The ViewMate® connects with an ultrasound catheter called ViewFlex® PLUS that is inserted into the heart via intravascular access. The ViewFlex® PLUS catheter, illustrated in Figure 2, is a single use, temporary, intracardiac ultrasound catheter indicated for use in adult and adolescent pediatric patients. ViewFlex® PLUS mechanical properties are as follows: The catheter shaft is 9 French, approximately 90 cm long, constructed of radio-opaque tubing. The catheter offers bi-directional steerability that can be A minimum of a 10 French introducer is manipulated with one hand.

This document is the property of EPMedSystems. Its' entire content is considered proprietary and confidential by EP MedSystems. This document may not be copied, reproduced, published to others, in whole or in part, without express written consent of EPMedSystems' executive management.

File: VF-PM Sp510(k) Summary

Page 3 of 6

{3}------------------------------------------------

407 3300

Image /page/3/Picture/1 description: The image contains the logo for EPMedSystems. The logo consists of a stylized graphic to the left of the company name. The text "EPMedSystems" is written in a serif font and is black.

ViewFlex™Catheter Modification VF-PM 510k Summary

recommended for use with this catheter for insertion into the femoral or jugular veins. ViewFlex® PLUS imaging properties are as follows: The catheter consists of a 64-element linear phased array, wideband transducer with an imaging frequency range of 4.5 MHz to 8.5 MHz, user-selectable magnification, 86° viewing angle on the ViewMate® I system and a viewing angle of 90° on the ViewMate® II system.

Image /page/3/Figure/4 description: The image shows a device with several labeled parts and measurements. The device includes a "CARD EDGE CONNECTOR" on the left, followed by a section measuring "115cm". Further along, there's a "HANDLE", a "9FR SHAFT", and a "DEFLECTION AREA" leading to a "TRANSDUCER" on the right, which is measured at "90cm".

Figure 2: ViewFlex® PLUS Catheter

  • 8.7. Change Scope and Description: The intent of this submission is to provide premarket notification of modifications to the mechanical design of the ViewFlex® catheter; the modified device will be marketed as ViewFlex® PLUS catheter (model VF-PM). The intended use and indications for use of the ViewFlex® catheter are not affected. No changes have been made to the ultrasound or electronics design of the catheter; the ultrasound transducer and its performance is not affected by the proposed changes. Similarly, no changes have been made to the ViewMate® The catheter modification is or the ViewMate® II (PMS HD11 XE) console. intended to satisfy the broadening range of ICE (IntraCardiac Echo) user needs that have been realized since the product's original release (K031066). Specifically, the modification increases the range of angulation (i.e., bending of the distal tip measured in degrees) and increases the stability (i.e., firmness) of the positioned catheter. In addition to meeting a broader range of user needs, these changes position the product more competitively in the market place. EPMedSystems employed design controls, including verification and validation in the design change process. The changes are detailed in Appendix 6 and in the supporting documentation provided. The following table summarizes the changes.
    This document is the property of EPMedSystems. Its' entire content is considered proprietary and confidential by EP Mis document is the proporty of an insural, published or disclosed to others, in whole or in part, without express written consent of EPMedSystems' executive management.

{4}------------------------------------------------

K73702

Image /page/4/Picture/1 description: The image shows the logo for EPMedSystems. The logo consists of a stylized graphic to the left of the text "EPMedSystems". The graphic is a black, abstract shape. The text is in a serif font and is also black.

ViewFlex™Catheter Modification VF-PM 510k Summary

Change#ChangeClassificationChange DescriptionReason
1Finished product,externalmodificationReduce usable length from110cm to 90 cmExtra 20cm is not usedin right heartcatheterizations.Competitive product is90cm.
2Finished product,external materialchange andperformancechangeReplace covering of distaltransfer section with 35DPEBAX® with metal braidingExtending the braidingto the transducerincreases catheterstability
3Finished product,internal materialchangeReplace steering wires with0.003" x 0.010" stainlesssteel wireSatisfy broadened userrequirements -- increasedeflection range
4Finished product,internal materialchangeAdd one Teflon® tube overindividual steering wiresSatisfy broadened userrequirements - increasedeflection range
5Finished product,internal materialchangeReplace adhesive bondingshaft to the transducer withFDA 2 epoxy.Increase productionyield
6Finished product,internal materialchangeReplace wire post (0.062"OD) pin with (0.220" OD)tubeSatisfy broadened userrequirements - increasedeflection range
7Finished product,internal materialchangeAdd Advanced Polymer heatshrink 140250 at proximaljointSatisfy broadened userrequirements - increasedeflection range
8Production processchangeEliminate gluing of transfersection cover, employ heatfusing and continuousbraidingIncrease productionyield
9PerformancechangeIncreased angulation from±30° to ±120°Satisfy broadened userrequirements - increasedeflection range
Table 1: ViewFlex® Catheter Change Summary
------------------------------------------------
  • 8.8. Product Numbering Change Notice: In an effort to make it easier for customers to order catheters and to clarify product identification, EPMedSystems is modifying the way it refers to its ViewFlex® catheters. This is strictly a nomenclature change. The company currently uses VF-01 to represent the ViewFlex® catheter model number. Moving forward EPMedSystems will refer to the ultrasound products as follows in Table 2.
    This document is the property of EPMedSystems. Its' entire content is considered proprietery within and with and with with with with with with with with with with with with w mis document is the propery of Er modeled, reproduced, published or disclosed to others, in whole or in part, without express written consent of EPMedSystems' executive management.

{5}------------------------------------------------

c73709

Image /page/5/Picture/1 description: The image shows the logo for EPMedSystems. The logo consists of a stylized, abstract graphic to the left of the company name. The company name, "EPMedSystems," is written in a serif typeface, with the letters closely spaced together.

ViewFlex TMCatheter Modification VF-PM 510k Summary

Number DescriptionFormer NumberNew Number
Catheter Model Number1VF-01VF-PM
Ultrasonic Transducer ModelNumber2204PA 6.5/64
Catheter Part NumberVF-PA9F64E2DW3,409-20055
Product Code6VF-PA9F64E2DW3,4NA6

Table 2: Product Identification Change

Notes:

(1) "Catheter" and "Transducer" are not used synonymously.

(2) "Transducer" model refers to the active ultrasonic element commonly referred to as a piezoelectric crystal contained within the catheter - there is no change to this component, it is the same as that first cleared under K031066.

(3) "W" indicates wire added as part of the redesign (K071028); this differentiates the product by design.

(4) Units of former design (K031066) may also be sold as VF-PA9F64E2D.

(5) Part number is redesigned to accommodate additional curve sizes as the product line expands (e.g., 09-2003 for size 3, 09-2005 for size 5, 09-2007 for size 7).

(6) The company will no longer refer to the VF-PM by a numeric product code; company's internal device identification will be the part number. Note, this product code is not the same as the three digit FDA alpha product code used for device description/classification.

End of document

This document is the property of EPMedSystems. Its' entire content is considered proprietary and confidential by EP MedSystems. This document may not be copied, reproduced, published to others, in whole or in part, without express written consent of EPMedSystems' executive management.

File: VF-PM Sp510(k) Summary

{6}------------------------------------------------

Image /page/6/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the circle is an abstract symbol that resembles an eagle or a bird in flight.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAR 1 1 2008

EP MedSystems, Inc. c/o Mr. Larry Picciano Director of Regulatory Systems Cooper Run Executive Park 575 Route 73 North, Unit D West Berlin, NJ 08091

Re: K073709

ViewMate® System with ViewFlex® PLUS Catheter Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic Pulsed Doppler Imaging System Regulatory Class: Class II (two) Product Code: IYN, IYO, ITX, OBJ Dated: February 15, 2008 Received: February 19, 2008

Dear Mr. Picciano:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

This determination of substantial equivalence applies to the following transducers intended for use with the ViewMate® System, as described in your premarket notification:

ViewFlex® PLUS Catheter, Model VF-PM

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{7}------------------------------------------------

Page 2 - Mr. Larry Picciano

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html

If you have any questions regarding the content of this letter, please contact Lisa E. Leveille at (240) 276-4095.

Sincerely yours,

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{8}------------------------------------------------

Image /page/8/Picture/0 description: The image shows the logo for EPMedSystems. The logo consists of a stylized graphic to the left of the text "EPMedSystems". The graphic is a series of curved lines that form a shape resembling a heart or a flower. The text is in a bold, sans-serif font.

Cooper Run Executive Park 575 Route 73 North, Building D West Berlin, New Jersey 08091 (856)753-8533 Tel: (856)753-8544 Fax:

Indications for Use

Device Name: ViewMate® System (K073709)

Indications for Use: The ViewMate® System is indicated for use in adult and adolescent pediatric

patients to visualize cardiac structures and blood flow within the heart.

AND/OR Over-The-Counter Use Prescription Use で (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Division Sign-O
Division of Cardio
510(k) Number K073 Page 1 of 1

le: VF-PM Sp 510(k) Indcations for Use 122707

File: VF-PM Sp 510(k) Indcations for Use 122707

{9}------------------------------------------------

Re: K∅737∅9

Attachment: 4.2

Appendix F

Diagnostic Ultrasound Indications for Use Form

Fill out one form for each ultrasound system and each transducer.

intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Mode of Operation
Clinical ApplicationABMPWDCWDColorDopplerAmplitudeDopplerColorVelocityImagingCombined(specify)Other(specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (specify)
Intraoperative Neurological
Pediatric
Small Organ (specify)
Neonatal Cephalic
Adult Cephalic
Cardiac
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletalConventional
Musculo-skeletal Superficial
Other (specify)Pppρ

N= new indication; P= previously cleared by FDA; E= added under Appendix E

Additional Comments:
Cathete, Model: View Flex® PLUS
Ultrasound Element: PA 6.5/64
Catheter Model Number: VF-PM
Catheter Part Number: 09-2005

(Please DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

§ 892.1550 Ultrasonic pulsed doppler imaging system.

(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.